Literature DB >> 34295086

Trends in Axillary Management of Early Breast Cancer: a Questionnaire-Based Pattern of Practice Survey for India.

Sanjit Kumar Agrawal1, Noopur Priya1, Pooja Agarwal1, Abhishek Sharma1, Soumitra Shankar Datta2, S V S Deo3, Rosina Ahmed1.   

Abstract

Surgical management of breast cancer (BC) has evolved from radical surgeries to conservative with better cosmetic and comparable oncological outcomes. For axillary staging, it has evolved from axillary lymph node dissection (ALND) to sentinel lymph node biopsy (SLNB). No detailed information exists in terms of the clinical practice pattern of surgical management of axilla for BC patients in India. A questionnaire-based survey was developed. The survey was done at the annual meeting of the Association of Breast Surgeons of India (ABSI) in November 2018. Responses were recorded and analysed by SPSS 23. One hundred twelve out of 400 (28%) responded to the survey. Half of the respondents were surgical oncologist and 36.6% were performing > 150 BC surgeries/year. The primary technique for axillary staging in node-negative BC was SLNB for 68.5% of respondents. Majority of surgeons (47%) reported performing SLNB by methylene blue dye only. Unavailability of radioisotope (46.7%) and lack of frozen section (26.7%) were reported as two major barriers for not performing SLNB. Twenty-three percent did perform SLNB in post-NACT setting. Only 15.8% have omitted completion ALND in Z0011 trial eligible SLN-positive patients. 45.9% skipped completion ALND in SLN positive with micro metastasis only. Many surgeons in India are adopting SLNB as a method of axillary staging into their clinical practice. However, large number of surgeons still believe in conservative approach, most probably due to unavailability of resources and lack of Indian data. Barrier identified in this survey may be useful for future development. © Indian Association of Surgical Oncology 2021.

Entities:  

Keywords:  Breast cancer; India; Sentinel lymph node biopsy; Survey

Year:  2021        PMID: 34295086      PMCID: PMC8272771          DOI: 10.1007/s13193-021-01334-4

Source DB:  PubMed          Journal:  Indian J Surg Oncol        ISSN: 0975-7651


  28 in total

1.  A further survey of surgical management of the axilla in UK breast cancer patients.

Authors:  Ronan W Glynn; Linda Williams; J Michael Dixon
Journal:  Ann R Coll Surg Engl       Date:  2010-06-01       Impact factor: 1.891

2.  Assessing patterns of practice of sentinel lymph node biopsy for breast cancer in Latin America.

Authors:  Sergio A Acuna; Fernando A Angarita; Jaime Escallon
Journal:  World J Surg       Date:  2014-05       Impact factor: 3.352

3.  Changing behavior in clinical practice in response to the ACOSOG Z0011 trial: a survey of the American Society of Breast Surgeons.

Authors:  Sarah M Gainer; Kelly K Hunt; Peter Beitsch; Abigail S Caudle; Elizabeth A Mittendorf; Anthony Lucci
Journal:  Ann Surg Oncol       Date:  2012-07-21       Impact factor: 5.344

4.  Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial.

Authors:  Viviana Galimberti; Bernard F Cole; Giuseppe Viale; Paolo Veronesi; Elisa Vicini; Mattia Intra; Giovanni Mazzarol; Samuele Massarut; Janez Zgajnar; Mario Taffurelli; David Littlejohn; Michael Knauer; Carlo Tondini; Angelo Di Leo; Marco Colleoni; Meredith M Regan; Alan S Coates; Richard D Gelber; Aron Goldhirsch
Journal:  Lancet Oncol       Date:  2018-09-05       Impact factor: 41.316

5.  Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC study.

Authors:  Jean-Francois Boileau; Brigitte Poirier; Mark Basik; Claire M B Holloway; Louis Gaboury; Lucas Sideris; Sarkis Meterissian; Angel Arnaout; Muriel Brackstone; David R McCready; Stephen E Karp; Isabelle Trop; Andre Lisbona; Frances C Wright; Rami J Younan; Louise Provencher; Erica Patocskai; Atilla Omeroglu; Andre Robidoux
Journal:  J Clin Oncol       Date:  2014-12-01       Impact factor: 44.544

6.  Efficacy of Sentinel Lymph Node Biopsy in Detecting Axillary Metastasis in Breast Cancer Using Methylene Blue.

Authors:  Vipul V Nandu; Milind S Chaudhari
Journal:  Indian J Surg Oncol       Date:  2016-12-28

7.  Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial.

Authors:  Robert E Mansel; Lesley Fallowfield; Mark Kissin; Amit Goyal; Robert G Newcombe; J Michael Dixon; Constantinos Yiangou; Kieran Horgan; Nigel Bundred; Ian Monypenny; David England; Mark Sibbering; Tholkifl I Abdullah; Lester Barr; Utheshtra Chetty; Dudley H Sinnett; Anne Fleissig; Dayalan Clarke; Peter J Ell
Journal:  J Natl Cancer Inst       Date:  2006-05-03       Impact factor: 13.506

8.  Patterns of clinical practice for sentinel lymph node biopsy in women with node-negative breast cancer: the results of a national survey in Japan.

Authors:  Takafumi Ikeda; Tomoharu Sugie; Akira Shimizu; Masakazu Toi
Journal:  Breast Cancer       Date:  2016-08-27       Impact factor: 4.239

9.  Abandoning sentinel lymph node biopsy in early breast cancer? A new trial in progress at the European Institute of Oncology of Milan (SOUND: Sentinel node vs Observation after axillary UltraSouND).

Authors:  Oreste Gentilini; Umberto Veronesi
Journal:  Breast       Date:  2012-07-25       Impact factor: 4.380

10.  The feasibility of the ACOSOG Z0011 Criteria to Chinese Breast Cancer Patients: A Multicenter Study.

Authors:  Miao Liu; Shu Wang; Shude Cui; Xuening Duan; Zhimin Fan; Zhigang Yu
Journal:  Sci Rep       Date:  2015-10-16       Impact factor: 4.379

View more
  2 in total

1.  Diagnostic performance and survival outcome following sentinel lymph node biopsy in breast cancer patients from a tertiary cancer centre in India.

Authors:  Sanjit Kumar Agrawal; Himanshu Sharma; Noopur Priya; Anoop P Saji; Hamyung Denchu Phom; Abhishek Sharma; Indu Arun; Jayanta Das; Aditi Chandra; Rosina Ahmed
Journal:  Ecancermedicalscience       Date:  2022-05-26

2.  Effect of non-sentinel metastasis on adjuvant treatment decisions and survival in Z0011 eligible non-screened detected breast cancer population.

Authors:  Sanjit Kumar Agrawal; Vishal Kewlani; Noopur Priya; Abhishek Sharma; Joydeep Ghosh; Sanjoy Chatterjee; Rosina Ahmed
Journal:  Ecancermedicalscience       Date:  2021-11-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.